|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| G01N 33/577 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Patento numeris | 2808032 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14166211.4 |
| Europos patento paraiškos padavimo data | 2006-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-12-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 05027092 | 2005-12-12 | EP | |
| 06014729 | 2006-07-14 | EP | |
| 06020766 | 2006-10-02 | EP |
| (72) |
Greferath, Ruth, DE
Hickman, David, CH
Muhs, Andreas, CH
Pfeifer, Andrea, CH
Nicolau, Claude, US
|
| (73) |
AC Immune S.A.,
EPFL Innovation Park Building B, 1015 Lausanne,
CH
|
| (54) | A BETA 1-42 SPECIFIC MONOCLONAL ANTIBODIES WITH THERAPEUTIC PROPERTIES |
| A BETA 1-42 SPECIFIC MONOCLONAL ANTIBODIES WITH THERAPEUTIC PROPERTIES |